Rare CFTR large deletions
a series of cases
DOI:
https://doi.org/10.15448/1980-6108.2023.1.44600Keywords:
genetics, diagnosis, newborn screening, sweat chloridAbstract
Aims: this paper aims to describe diagnosis and follow-up of patients affected by the Cystic Fibrosis (CF) manifestations and CFTR large deletions. For this, we performed a retrospective analysis of medical records, including genotyping and retrospective follow-up of clinical and lung function data. Electronic and printed medical records of patients followed at a referral outpatient clinic in CF were evaluated. Case description: we found that three patients had large deletions in the CFTR gene, being two of them heterozygous (heterozygous with deletion on exons from 2 to 3, and heterozygous for deletions on exons from 25 to 27) and one of them homozygous (homozygous for the deletions on exons from 19 to 21). One patient had a false negative result in complete genetic sequencing. All three received standard treatment for CF. Two patients died from CF pulmonary complications. Therefore, false negatives findings in CFTR sequencing for the diagnosis of CF are rare but may be more frequent in patients with large deletions. Conclusions: CFTR large deletions are associated with severe CF phenotypes.
Downloads
References
Silva Filho LR, Maróstica PC, Athanazio RA, Kok F, Amaral MD, et al. The brazilian cystic fibrosis patient registry contributors team. Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country. J Cyst Fibros. 2021;20(3):473-84. https://doi.org/10.1016/j.jcf.2020.08.007
Férec C, Casals T, Chuzhanova N, Macek M, Jr, Bienvenu T, Holubova A, et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes
and meta-analysis of underlying mechanisms. Eur J Hum Genet. 2006;22:1–10. https://doi.org/10.1038/sj.ejhg.5201590
Yang B, Lei C, Yang D, Tan Z, Guo T, Luo H. Wholeexome sequencing identified CFTR variants in two consanguineous families in China. Front Genet. 2021;12:929. https://doi.org/10.3389/fgene.2021.631221
Roelse JED, Bouva MJ, Jakobs BS, Janssens HM, Groot KMW, Schönbeck Y, Gile JJP, Gulmans VAM, Puite RKV, Schielen PCJI et al. Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands. J Cyst Fibros. 2019;18(1):54-63. https://doi.org/10.1016/j.jcf.2018.07.008
Niel F, Martin J, Dastot-Le Moal F, Costes B, Boissier B, Delattre V, Goossens M, Girodon E. Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis. J Med Genet. 2004;41:e118. http://dx.doi.org/10.1136/jmg.2004.022400
Rigot JM, Lafitte JJ, Dumur V, Gervais R, Manouvrier S, Biserte J, Mazeman E, Roussel P. Cystic Fibrosis and Congenital Absence of the Vas Deferens. N Engl J Med. 1991;325:64-5. http://dx.doi.org/10.1056/NEJM199107043250116
Essawi O, Farraj M, De Leeneer K, Steyaert W, De Pauw K, De Paepe A, et al. Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population. Disease Markers 2015;2015. https://doi.org/10.1155/2015/458653
US CF Founfation. The clinical and functional translation of CFTR (CFTR2) [Internet]. Cftr2.org. Copyright 2011 US CF Foundation, John Hopkins University, The Hospital for Sick Children; 2023 [cited 2023 Oct 16]. Available from: https://cftr2.org.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Scientia Medica
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
